In contrast, intravenous hematin (which is very similar to heme preparations used in the former experiments) used in patients with porphyria is not associated with a systemic hypercoagulable state, and has been previously associated with prolongation of coagulation times and to reduced levels of coagulation factors V and VIII [41,42]. The gene discussed is F5; the disease is porphyria.